Therefore, we performed logistic analyses for PFS at 1 year after CAR-T infusion using these 4 parameters and found them significant or marginally significant (Table 2 ).
← all excerpts
Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy.
1
—
—